MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study

<div>The prognosis analysis of MYL5 expression in the TCGA dataset. The effects of MYL5 expression on overall survival (a) and disease free survival (b) in different tumors were analyzed by using the GEPIA 2 tool. The survival map and Kaplan–Meier curves with positive results were displayed.</div>

The Breast Journal

fig2

Figure 2

Figure 2: MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study 